Abstract Arsenic trioxide (As 2 O 3 ) has recently been successfully used to treat all trans retinoic acid (ATRA) resistant relapsing acute promyelocytic leukemia. However, its molecular mechanisms of action are poorly understood. In the present study, we used the human leukemia (HL-60) cell line as a test model to study the cellular and molecular mechanisms of anti-cancer properties of As 2 O 3 . We hypothesized that As 2 O 3 -induced expression of stress genes and related proteins may play a role in the cellular and molecular events leading to cell cycle modulation in leukemic cells. To test this hypothesis, we performed Western blot analysis to assess the expression of specific cellular response proteins including p53, c-fos, RARE, Cyclin A, and Cyclin D1. Densitometric analysis was performed to determine the relative abundance of these proteins. Western Blot and densitometric analyses demonstrated a strong dose-response relationship with regard to p53 and RARE expression within the dose-range of 0-8 lg/ml. Expression of c-fos was slightly up-regulated at 2 lg/ml, and down-regulated within the dose-range of 4-8 lg/ml. A statistically significant down-regulation of this protein was detected at the 6 and 8 lg/ml dose levels. No statistically significant differences (p [ 0.05) in Cyclin D1 expression was found between As 2 O 3 -treated cells and the control. Cyclin A expression in As 2 O 3 -treated HL-60 cells was up-regulated at 6 lg/ml, suggesting that it is required for S phase and passage through G 2 phase in cell cycle progression. Taken together, these results indicate that As 2 O 3 has the potential to induce cell cycle arrest through activation of the 53-kDa tumor suppressor protein and repression of the c-fos transcription factor. Up-regulation of RARE by As 2 O 3 indicates that its cytotoxicity may be mediated through interaction/binding with the retinoic acid receptor, and subsequent inhibition of growth and differentiation.
Introduction
Arsenic trioxide (As 2 O 3 ) is an arsenic-containing drug that has recently been used as a therapeutic agent in the treatment of patients who have relapsed from acute promyelocytic leukemia (APL). APL is a subtype of acute myelogenous leukemia (AML), defined by the World Heath Organization classification. It is caused by a specific translocation [t(15;17)(q22;q21.1)] between the promyelocytic leukemia gene on chromosome 15, and the retinoic acid receptor alpha (RARa) gene chromosome 17. This translocation leads to the production of a fusion protein (PML/RARa) which causes failure of promyelocytes to differentiate, and blocks apoptosis. Recent studies have shown that As 2 O 3 can induce a clinical remission in patients with APL. Arsenic-containing compounds have been reported to induce apoptosis in leukemic cells both in vivo and in vitro [1] . Many studies on APL-derived cell lines and transgenic mice carrying the PML/RARa fusion proteins indicate that As 2 O 3 induces degradation of both PML/RARa and native PML from the nuclei of the malignant cells [2, 3] . This process allows partial differentiation of leukemia population to proceed. In vitro studies on APL-derived leukemia cells have also indicated that As 2 O 3 causes disappearance of both mutant PML/RARa and wild type PML from the nucleus, eliminating its dominant negative oncogenic effect and leading to terminal maturation of the malignant cells [3] .
Recent studies have also indicated that arsenic induces neoplastic cell transformation and apoptosis in tumor cells, by significantly affecting specific signal transduction pathways and by activating the expression of AP-1 and nuclear factor kappa B (NF-jB) in JB 6 cells [4, 5] . Other laboratory studies using myeloid leukemia cell lines that do not express PML-RARa have shown that melarsoprol and As 2 O 3 inhibit cell growth, downregulate Bcl-2 protein, and induce apoptosis [6] .
Although As 2 O 3 in vitro influences signal transduction pathways in tumor cells, its specific molecular mechanisms of action remain to be elucidated. In the present study, we hypothesized that As 2 O 3 -induced expression of stress genes and related proteins plays a role in the molecular events leading to cell cycle modulation in leukemic cells. To test this hypothesis, we performed the western blot and densitometric analyses to assess the expression and relative abundance of specific cellular proteins including p53, c-fos, RARE, cyclin A, and cyclin D1 in human leukemia cells exposed to As 2 O 3 .
Materials and methods

Chemicals and test media
Arsenic trioxide (As 2 O 3 ), CASRN 1327-53-3, MW 197.84, with an active ingredient of 100% (w/v) arsenic in 10% nitric acid was purchased from Fisher Scientific (Houston, Texas, U.S.A). Growth medium RPMI 1640 containing 1 mmol/L L-glutamine was purchased from Gibco BRL products (Grand Island, NY). Ninety-six well plates were obtained from Costar (Cambridge, MA). Fetal bovine serum (FBS), antibiotics (penicillin G and streptomycin), and phosphate buffered saline (PBS) were obtained from Sigma Chemical Company (St. Louis, MO).
Tissue culture
The HL-60 promyelocytic leukemia cell line was purchased from the American Type Culture Collection--ATCC (Manassas, VA). This cell line has been derived from peripheral blood cells of a 36-year old Caucasian female with acute promyelocytic leukemia (APL). The HL-60 cells grow as a suspension culture. The predominant cell population consists of neutrophilic promyelocytes [7] .
In the laboratory, cells were stored in the liquid nitrogen until use. They were next thawed by gentle agitation of their containers (vials) for 2 min in a water bath at 37°C. After thawing, the content of each vial of cell was transferred to a 25 cm 2 tissue culture flask, diluted with up to 10 ml of RPMI 1640 containing 1 mmol/L L-glutamine (GIBCO/BRL, Gaithersburg, MD) and supplemented with 10% (v/v) fetal bovine serum (FBS), 1% (w/v) penicillin/ streptomycin. The 25 cm 2 culture flasks (2 9 10 6 viable cells) were observed under the microscope, followed by incubation in a humidified 5% CO 2 incubator at 37°C. Three times a week, they were diluted under same conditions to maintain a density of 5 9 10 5 /ml, and harvested in the exponential phase of growth. The cell viability was assessed by the trypan blue exclusion test (Life Technologies), and manually counted using a hemocytometer.
Western blot and densitometric analyses
Western blot analysis was conducted to determine specific cellular response proteins including p53, Cyclin A, Cyclin D1, RARE, and c-fos at 24 h of arsenic trioxide (As 2 O 3 ) exposure. HL-60 cells were grown in 96 well polystyrene tissue plates. Briefly, 200 lL cells (5 9 10 5 /ml) were added to each well of 96 tissue culture plates and treated with 2, 4, 6, and 8 lg/ml of As 2 O 3 for 24 h. These doses were selected based on the results of previous experiments in our laboratory indicating that As 2 O 3 is cytotoxic to HL-60 cells, showing a 24 h LD 50 of 6.4 ± 0.7 lgml [8] . Control well plates were also made without As 2 O 3 . After the incubation period, cells were centrifuged at 800 rpm for 5 min, the supernatant was carefully aspirated, and the cells were washed twice with PBS. The total protein was measured by the Bradford method at 600 nm using a microtiter plate reader [9] . Twenty microliters of native sample buffer (0.2 mol/l Tris, pH 6.8, 1% SDS, 30% glycerol, 7.5% mercaptoethanol, 0.1% bromophenol blue) were added to each plate well and the cells were mechanically collected into micro-centrifuge tubes. Cellular protein lysates (15 lg/ml) from human leukemia HL-60 cells containing an equal volume of sample buffer were heated at 100°C for 10 min. Appropriate amounts of total cellular protein were loaded onto 10% SDS polyacrylamide gels and electrophoresed constantly at 100 V for 1 h. Samples were transferred onto a nitrocellulose membrane on ice and the membrane was blocked (Tris buffer saline with 5% nonfat dry milk, 0.1 Tween 20) for 24 h at 4°C. Detection of membrane-bound proteins was carried out using specific primary antibodies for the proteins of interest (c-fos 15:1000, p53 1:1000, RARE 1:500, Cyclin A 1:500, and Cyclin D1 1:750) (Santa Cruz Biotechnology Inc., Santa Cruz, CA). Equal lane loading was assessed using a-tubulin mouse monoclonal primary antibody (Fig. 1) . Subsequently, the reaction was probed with a 1:750 dilution of alkaline conjugated anti-mouse IgG secondary antibody. NBT/BCIP color substrate was incorporated to develop protein bands. Immunoblot 1-D protein bands were assessed for relative abundances using Total LabImage computer software (Nonlinear USA Inc. Durham, NC).
Statistical analysis
In order to determine the lysate volumes to be loaded on the gels, protein samples collected from controls and As 2 O 3 -treated cells were measured using the Bradford method based on the optimal density readings at 600 nm. After electrophoresis, the expression levels of specific cellular proteins were photographed using the Gel Documentation System (Nucleotech Corporation, Inc, San Mateo CA). The experiments were performed three or more times to ensure reproducibility. Densitometric analysis was performed using the Gel Documentation System (Nucleotech Corporation, Inc, San Mateo CA) to determine the relative abundance of protein expression. Comparison of protein levels between control cells and As 2 O 3 -treated HL-60 cells was performed using one way analysis of variance (ANOVA) for multiple samples and Student's t-test for paired sample sets. All P-values \0.05 were considered to be significant.
Results
The expression and relative abundance levels of p53 in human leukemia (HL-60) cells exposed to arsenic trioxide (As 2 O 3 ) are represented in Fig. 2 . According to ANOVA Dunnett's test (P \ 0.05), western blot and the densitometric analyses demonstrated a significant increase of p53 expression in As 2 O 3 -treated HL-60 cells showing a gradual increase in protein expression with increasing doses of As 2 O 3 .
The relative level of c-fos expression was slightly up-regulated at 2 lg/ml, and down-regulated within the dose-range of 4-8 lg/ml. Statistically significant downregulation of this protein was detected at the 6 and 8 lg/ml dose levels. Hence, c-fos expression data indicated a somewhat biphasic response that encompasses up-regulation at 2 lg/ml level of exposure and down-regulation at higher doses of exposure (Fig. 3) .
The data of RARE expression in As 2 O 3 -treated cells are represented in Fig. 4 . As shown in this figure, the expression of RARE in HL-60 cells exposed to As 2 O 3 at 2, 4, and 6 lg/ml dose levels are not significantly different (P [ 0.05) compared to the control. However, an up-regulation of this protein was observed in As 2 O 3 -treated cells with a statistically significant increase at 8 lg/ml compared to the control.
Western blot analysis showed a slight increase in cyclin D1 expression in As 2 O 3 -treated HL-60 cells. However, the statistical analysis based on the densitometric analysis did not show any significant differences (P [ 0.05) between As 2 O 3 -treated cells and the control (Fig. 5) . Data on cyclin A expression and its relative abundance in As 2 O 3 -treated HL-60 cells are represented in Fig. 6 . As shown in this figure, there was no statistically significant difference between the control and As 2 O 3 -treated cells up to 4 lg/ml dose levels. An up-regulation of this protein was detected at 6 lg/ml of As 2 O 3 , suggesting that it is likely required for S phase and passage through G2 phase in cell cycle progression. However, at 8 lg/ml of As 2 O 3 treatment, the expression of this protein was similar to that of the control.
Discussion
The present study was designed to investigate the influence of arsenic trioxide (As 2 O 3 ) treatment on the expression of p53, c-fos, RARE, cyclin A, and cyclin D1 in human leukemia (HL-60) cells. Data from western blot and densitomentric analyses show a gradual increase of p53 expression in HL-60 cells with increasing doses of As 2 O 3 compared to the control. We also detected an expression of p53 in untreated HL-60 cells (control cells). The p53 expression was further up-regulated in As 2 O 3 -treated HL-60 cells compared to the control (Fig. 2) . Although HL-60 cells are known as p53 null human acute promyelocytic leukemia cell line, we found that they may express p53 protein as revealed by the western blot analysis. Consistent with our findings, Powles et al. have detected p53 expression in HL-60 and CEM cells exposed to tetrahydrocannabinol using immunoblot analysis [10] . Numerous studies have also indicated that arsenic induces mitotic arrest and apoptosis in cells lacking functional p53 such as SV40-transformed human fibroblasts, Hela, and U937 cells [11] [12] [13] [14] . On contrary, previous researches have demonstrated that HL-60 cells are p53 null or do not express p53 because of the large deletions of p53 gene in human promyelocytic leukemia (HL-60) cells [15] . Based on these controversial reports in regard to p53 expression in HL-60 cells, further research is needed to explain the differences.
The increased expression of the 53 KDa tumor suppressor protein detected in the As 2 O 3 -treated HL-60 cells [16] , oxidative stress [17, 18] , UV irradiation [19, 20] , and transcriptional blockade [21] induce translocation of p53 to the mitochondria. Research has suggested that arsenic induces DNA damage, such as chromosome aberration [22] , and sister chromatid exchange [23] . Because p53 mutations are common in most human cancers and apoptosis plays a key role in the bioactivity of most chemotherapeutic agents, As 2 O 3 seems to be very useful for the treatment of APL and certain human cancers. This notion is supported by the findings that p53 is the most commonly mutated tumor suppressor gene, and the lack of p53 activation or expression is associated with an increased risk of tumor formation [24] [25] [26] . Previous studies in our laboratory have demonstrated that As 2 O 3 is able to transcriptionally induce the expression of p53, c-fos, and HSP70 in human liver carcinoma (HepG 2 ) cells [27] . The p53 transcription factor has been shown to mediate apoptosis through its direct action at the mitochondria [28, 29] .
The result of c-fos expression shows a somewhat biphasic response that encompasses a slight up-regulation at lower doses of exposure, and down-regulation at higher doses of exposure. The inhibition of c-fos expression at higher level of As 2 O 3 exposure is in agreement with the activation of p53 expression, suggestive of cell cycle arrest at G1 check point of the cell cycle. p53 has been shown to repress regulators of cell proliferation, such as c-fos and c-jun which are early-response nuclear oncogenes [30] . Many researchers have reported that c-fos and p53 share similar function and similar transcriptional regulatory pathways in apoptosis following excitotoxic stimulation [31, 32] . Findings from the present study implies that c-fos repression may play an important role in HL-60 cells apoptosis induced by As 2 O 3 . c-fos is known to be highly induced in many human cancer cell lines in response to stimulus. This proto-oncogene (c-fos) plays a role in cell proliferation, differentiation, and may contribute to tumor promotion. In other cell lines, As 2 O 3 has been reported to activate the expression of c-fos through numerous signal transduction pathways at low dose of exposure. For example, in a human bladder epithelial cell line, arsenic increased cell proliferation and AP-1 DNA binding [33] .
In mammalian cells, cyclins D, E, and A are key cyclins involved in G1 to S phase transition. Cyclin D assembles with cdk4/6 in early G1; cyclin E combines with cdk2 later in G1, and cyclin A associates with cdk2 at the beginning of S phase [34, 35] . In the present study, the data of western blot and densitometric analyses show a slight increase of Cyclin D1 expression in As 2 O 3 -treated HL-60 cells. However, there were no statistically significant differences (P [ 0.05) in cyclin D1 expression between As 2 O 3 -treated cells and the control. The lack of a statistically significant difference in cyclin D1 expression in As 2 O 3 -treated cells compared to the control is in agreement with the activation of the p53 tumor suppressor protein, and the repression of the c-fos proto-oncogene, indicative of cell cycle arrest at the G1/S checkpoint. Few studies have demonstrated that cyclin D1 over-expression does not correlate with the proliferation rate in rat mammary tumors or in human tumors [36, 37] . Data generated from the present study show that As 2 O 3 doesn't significantly affect progression from G 0 /G 1 into S phase. This transition is, in part, controlled by the activity of G 1 cyclin-cdk's which include D cyclins associated with either cdk4 or cdk6 and E cyclins associated with cdk2 [38, 39] , suggesting that the expression of cyclin D1 may be an early event in chemical tumorigenesis, causing an increase in cell proliferation.
Recent publications have accumulated evidence showing an increased expression of cyclin D1 in tumor cell lines [40] [41] [42] . Studies have shown that arsenite exposure is able to activate the PI-3K/Akt pathway and induce cyclin D1 expression in mouse epidermal Cl41 cells [43] . It has been reported that mitogen-activated protein kinase (MAPK) cascades are involved in the modulation of cyclin D1 expression [44] . Other studies have revealed that ectopic expression of cyclin D1 can shorten the G 1 phase, whereas inhibition of cyclin D1 expression blocks G 1 -S transition. It has been demonstrated that carcinogenic compounds can induce cyclin D1 expression, which in turn promote tumor cell proliferation [45] .
Data generated from the present study have demonstrated a positive expression of cyclin A in As 2 O 3 -treated HL-60 cells showing an up-regulation at 6 lg/ml of As 2 O 3 exposure. Cyclin A is required in more than one phase of the cell cycle. It is one of the first cyclins to be identified and is believed to function between that of cyclin E and cyclin B. Generally, it is expressed in late S and G 2 phase and degraded during mitosis just prior to metaphase. It associates with two cyclin dependent kinases: cdk2 in the S phase of the cell cycle and Cdc2 in the G2/M phase. These associations are required for both DNA replication and mitosis [46] [47] [48] . Cyclin A is required for S phase and passage through G2 phase in cell cycle progression. Interestingly, our results indicated that treatment of HL-60 cells with As 2 O 3 may lead to cell cycle progression at the G 2 checkpoint as demonstrated by the significant increase of cyclin A expression at 6 lg/ml of As 2 O 3 exposure. The activation of cyclin A expression at higher level of As 2 expression; suggestive that exposure of human leukemia HL-60 cells to As 2 O 3 may result in an increase in the proportion of cells in mitosis. Up-regulation of the retinoic acid response element (RARE) in HL-60 cells by As 2 O 3 suggests that its toxicity may be mediated through interaction or binding with the retinoic acid receptor, and subsequent inhibition of growth and differentiation. Substantial data showed that As 2 O 3 exposure induces remission in patients with APL at least in part through a mechanism that results in the degradation of the aberrant PML-retinoic acid receptor-afusion protein. In the early 1980s, it was noted that all trans retinoic acid (ATRA) could induce differentiation of myeloid cell lines such as HL-60 [49] , and of primary cells from patients with APL [50] . The use of retinoids to suppress tumor development has been evaluated in several animal models of carcinogenesis, including models of skin, breast, oral cavity, lung, hepatic, gastrointestinal, prostatic, and bladder cancers [51] . Clinically, retinoids are able to reverse premalignant lesions and inhibit the development of primary tumors [52, 53] .
Conclusions
The present study provides new insights into the biochemical effects of arsenic trioxide (As 2 O 3 ) in HL-60 cells and the potential of As 2 O 3 as a chemotherapeutic agent for the treatment of acute promyelocytic leukemia. Using western blot and densitometric analyses, our data provide evidence that As 2 O 3 performs key functions of an anticancer agent against human leukemia; it is antiproliferative and apoptotic at high doses (p53 activation and c-fos repression), and induces cellular differentiation at low doses (cyclins D1 and A expression). These results are consistent with previous studies reporting that As 2 O 3 (an effective drug for the treatment of APL) exerts dosedependent dual effects in APL cells by triggering apoptosis and inducing partial differentiation [54] [55] [56] [57] .
Taken together, we have demonstrated in the present study that As 2 O 3 serves as an activator of the p53, RARE, cyclin A and cyclin D1, and a repressor of c-fos in HL-60 cells. It is evident that As 2 O 3 exposure places HL-60 cells under a degree of toxic stress that evokes response acting at different levels on the cell cycle. This toxic action of As 2 O 3 induces transcription of specific genes that affect mitogenic response, cell cycle progression, and programmed cell death. Findings from our studies suggest that activation of cyclin D1, cyclin A, and RARE by As 2 O 3 in HL-60 cells may be an important part of the multistep process involved in cell cycle progression, whereas the activation of the p53 tumor suppressor protein and repression of the c-fos transcription factor at higher level of exposure may be involved in cell cycle arrest and apoptosis. Further in vitro studies are underway to refine the molecular mechanisms of action and to determine whether signal transduction pathways vary according to the cell type, form of arsenic, or other factors.
